ORIGINAL COMMUNICATION

Journal of Neurology

, Volume 253, Issue 5, pp 612-617

First online:

Neurological complications after cadaveric and living donor liver transplantation

  • F. SanerAffiliated withFACS University Hospital Essen, Department of General Surgery and Transplantation Email author 
  • , Y. GuAffiliated withFACS University Hospital Essen, Department of General Surgery and Transplantation
  • , S. MinouchehrAffiliated withFACS University Hospital Essen, Department of General Surgery and Transplantation
  • , K. IlkerAffiliated withDepartment of Neurology, University Hospital Essen
  • , N. R. FruhaufAffiliated withFACS University Hospital Essen, Department of General Surgery and Transplantation
  • , A. PaulAffiliated withFACS University Hospital Essen, Department of General Surgery and Transplantation
  • , A. RadtkeAffiliated withFACS University Hospital Essen, Department of General Surgery and Transplantation
  • , M. DammannAffiliated withFACS University Hospital Essen, Department of General Surgery and Transplantation
  • , Z. KatsaravaAffiliated withDepartment of Neurology, University Hospital Essen
    • , S. KoeppenAffiliated withDepartment of Neurology, University Hospital Essen
    • , M. MalagóAffiliated withFACS University Hospital Essen, Department of General Surgery and Transplantation
    • , Ch. E. BroelschAffiliated withFACS University Hospital Essen, Department of General Surgery and Transplantation

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

Problems related to the central nervous system have a major impact on survival and quality of life. The aim of this retrospective study was to evaluate the incidence of neurological complications after liver transplantation (LT), including both cadaveric and living donor liver transplantation. Between April 2001 and March 2004 174 patients (120 cadaveric liver transplantations, 54 living donor transplantations) were admitted to our intensive care after liver transplantation. Of the transplanted patients 24.7% developed neurological complications. These patients’ stay in the intensive care (14.2 ± 17.2 days) was much longer than that of all admitted patients (8.4 ± 10.5 days, p < 0.05). The most common neurological complications were encephalopathy (72.1%) and seizures (11.6 %). The incidence of neurological complications in living donor liver transplanted patients was significantly lower than in cadaveric transplantation patients (20.4% vs 26.7 %). The cold ischemia time in living donor transplanted patients was significantly shorter in comparison with cadaveric transplanted patients (215 ± 119.3 vs. 383.7 ± 214.7). The survival rate after liver transplantation of patients with neurological complications was lower than that of patients without, but not significantly different (79.1 % vs. 82.4%, p > 0.05). The incidence of neurological symptoms was found to be similar between the patients treated with cyclosporine (25%) and tacrolimus (23.8 %) in this study. In conclusion, there was a high incidence of neurological complications after LT, prolonging the patients’ stay in intensive care significantly. The major neurological manifestation in our patients was encephalopathy followed by seizures. Living donor liver transplantation was associated with a significantly lower incidence of neurological complications compared with patients who had received a cadaveric graft. This might be due to the good quality of the organ and the much shorter cold ischemia time of the graft when the donor was alive.

Key words

encephalopathy liver transplantation neurological complication immunosuppression living donor